Abstract
We evaluated prostate cancer risk and family history of cancers using data from a case–control study in China. Cancer information among first-degree relatives was collected from 709 subjects (238 cases and 471 controls). None of the subjects reported a family history of prostate cancer. However, excess prostate cancer risk was associated with a family history of any cancer (OR=1.79, 95% CI: 1.21–2.63) and esophageal cancer (OR=2.39, 95% CI: 1.15–5.00). Nonsignificant risk was seen for family history of cancers of the stomach, lung, and female breast. Our results did not confirm the familial tendency toward prostate cancer but other cancers prevalent in China appeared to be aggregate, particularly esophageal cancer. Larger studies are needed to confirm these findings, and to clarify the genetic and lifestyle factors that may be involved.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hsing AW, Devesa SS . Trends and patterns of prostate cancer risk: what do they suggest? Epidemiol Rev 2001; 23: 3–13.
Hsing AW, Tsao L, Devesa SS . International trends and patterns in prostate cancer incidence and mortality. Int J Cancer 2000; 85: 60–67.
Parkin DM et al. (eds) Cancer Incidence in Five Continents, Vol 6. IARC Sci Publ 120. IARC, Lyon, France, 1992.
Hsing AW et al. Rising incidence of prostate cancer in Shanghai. Cancer Epidemiol Biomarkers Prev 1998; 7: 83–84.
Stanford JL, Ostrander EA . Familial prostate cancer. Epidemiol Rev 2001; 23: 19–23.
Steinberg GD et al. Family history and the risk of prostate cancer. Prostate 1990; 17: 337–347.
Whittemore AS et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995; 141: 732–740.
Ross RK et al. Case–control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst 1987; 78: 869–874.
Whittemore AS et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995; 87: 652–661.
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH . Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600–1608.
Hemminki K, Vaittinen P . Effect of paternal and maternal cancer on cancer in the offspring: a population-based study. Cancer Epidemiol Biomarkers Prev 1997; 6: 993–997.
Dhillon PK et al. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 2001; 93: 148–152.
Gronberg H, Bergh A, Damber JE, Emanuelsson M . Cancer risk in families with hereditary prostate carcinoma. Cancer 2000; 89: 1315–1321.
Bennett KE, Howell A, Evans DG, Birch JM . A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients. Br J Cancer 2002; 86: 718–722.
Damber L, Gronberg H, Damber JE . Familial prostate cancer and possible associated malignancies: nation-wide register cohort study in Sweden. Int J Cancer 1998; 78: 293–297.
Hayes RB et al. Prostate cancer risk in US blacks and whites with a family history of cancer. Int J Cancer 1995; 60: 361–364.
Hsing AW et al. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case–control study. Cancer Epidemiol Biomarkers Prev 2001; 10: 1077–1082.
Hsing AW et al. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case–control study in China. Cancer Res 2000; 60: 5111–5116.
Hsing AW et al. Body size and prostate cancer: a population-based case–control study in China. Cancer Epidemiol Biomarkers Prev 2000; 9: 1335–1341.
Hsing AW et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 2001; 93: 783–789.
SAS Institute Inc.: SAS/STAT Software. Changes and Enhancements through Release 6.12. SAS Institute Inc, Cary, NC, 1997.
Cerhan JR et al. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 1999; 8: 53–60.
Gao YT et al. Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer 1994; 58: 192–196.
Hu J et al. Risk factors for oesophageal cancer in northeast China. Int J Cancer 1994; 57: 38–46.
Yu MC et al. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res 1988; 48: 3843–3848.
Chan JM, Giovannucci EL . Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev 2001; 23: 82–86.
Cheng KK et al. Pickled vegetables in the aetiology of esophageal cancer in Hong Kong Chinese. Lancet 1992; 339: 1314–1318.
Yu Y et al. Retrospective cohort study of risk factors for esophageal cancer in Linxian, People's Republic of China. Cancer Causes Control 1993; 4: 195–202.
Platz EA, Helzlsouer KJ . Selenium, zinc, and prostate cancer. Epidemiol Rev 2001; 23: 93–101.
Taylor PR et al. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China Linxian Nutrition Intervention Trials Study Group. Cancer Res 1994; 54: s2029–s2031.
Xing D-Y, Tan W, Song N, Lin D-X . Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 2001; 95: 140–143.
Xu J et al. Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res 2002; 62: 2253–2257.
Dietzsch E, Laubscher R, Parker MI . Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene. Int J Cancer 2003; 20: 38–45.
Rothman KJ, Greenland S . Modern Epidemiology, 2nd edn. Lippincott-Raven, Philadelphia, 1998; pp 225–229.
Acknowledgements
We thank the staff at the Shanghai Cancer Institute and the collaborating hospitals and urologists for data collection, and the pathologists for pathology review. We also thank Linda Lannom, John Heinrich, Nancy Odaka, Kimberly Viskul, Mille Bendel, and Harvey Co Chien of Westat Inc., as well as Mary McAdams, Jean Cyr, and Leslie Carroll of Information Management Systems, Inc., for data preparation and management.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bai, Y., Gao, YT., Deng, J. et al. Risk of prostate cancer and family history of cancer: a population-based study in China. Prostate Cancer Prostatic Dis 8, 60–65 (2005). https://doi.org/10.1038/sj.pcan.4500775
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500775
Keywords
This article is cited by
-
First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis
BMC Cancer (2019)
-
Association between family history of prostate cancer and positive biopsies in a Brazilian screening program
World Journal of Urology (2013)
-
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort
Asian Journal of Andrology (2012)